Key Proteo

Seattle, United States

Key Proteo is a developer of a novel peptide screening for newborn babies.

$3.0M raised

May 2023

Seed

Top Investors

Mint Venture Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Key Proteo raised?

Key Proteo has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in May 2023.

Who are Key Proteo's investors?

Key Proteo's investors include Mint Venture Partners.

Where is Key Proteo headquartered?

Key Proteo is headquartered in Seattle, United States.

What does Key Proteo do?

Key Proteo is a developer of a novel peptide screening for newborn babies.

What stage is Key Proteo at?

Key Proteo is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 16, 2023.

MLA

"Key Proteo — Funding & Investors." VCBacked, May 16, 2023, https://www.vcbacked.co/company/key-proteo. Accessed June 10, 2026.

APA

VCBacked. (2023). Key Proteo — Funding & Investors. Retrieved June 10, 2026, from https://www.vcbacked.co/company/key-proteo

Wikipedia (cite web)

{{cite web |title=Key Proteo — Funding & Investors |url=https://www.vcbacked.co/company/key-proteo |website=VCBacked |access-date=June 10, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 16, 2023.